NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Filing Date
Dec 31, 2025
Global Rank
#61
/ 8,420
Top Industry
Semiconductors
10.5%
3Y Alpha vs SPY
-13.9%
Period ended 5 months ago
Filed Feb 17, 2026 · 4mo
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+5.3%
SPY
+9.1%
Annualised alpha
-13.5%
Max drawdown
−8.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1,153 positions · as of Dec 31, 2025Top Position
4.7%
of portfolio value
Top 5
16.3%
of portfolio value
Top 10
22.0%
of portfolio value
HHI
82
Diversified
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 28.5% | $18,308,870,425 |
| Financial Services | 14.2% | $9,133,187,001 |
| Healthcare | 11.9% | $7,621,824,594 |
| Industrials | 10.8% | $6,916,717,425 |
| Consumer Cyclical | 10.8% | $6,907,671,408 |
| Communication Services | 6.6% | $4,223,576,996 |
| Real Estate | 5.6% | $3,596,295,590 |
| Utilities | 3.6% | $2,327,386,585 |
| Energy | 3.0% | $1,895,698,705 |
| Basic Materials | 2.6% | $1,644,953,591 |
| Consumer Defensive | 2.4% | $1,564,368,433 |
| Unclassified | 0.0% | $15,384,327 |
171 positions ·
$7,621,824,594 total
· Healthcare only
· as of Dec 31, 2025
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Showing 1–50
of 171 positions by value
· page 1 of 4
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GILD |
Gilead Sciences, Inc.
Healthcare
|
First | 3,559,632 | $436,909,230 | 5.73% | |
| DHR |
Danaher Corp /De/
Healthcare
|
First | 1,801,854 | $412,480,417 | 5.41% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
First | 623,235 | $352,975,374 | 4.63% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
First | 432,059 | $292,300,874 | 3.84% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
First | 389,077 | $225,450,667 | 2.96% | |
| VEEV |
Veeva Systems Inc
Healthcare
|
First | 955,392 | $213,272,155 | 2.80% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
First | 1,963,787 | $206,708,218 | 2.71% | |
| INSM |
INSMED Inc
Healthcare
|
First | 1,183,029 | $205,894,367 | 2.70% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
First | 989,447 | $180,712,600 | 2.37% | |
| ABBV |
AbbVie Inc.
Healthcare
|
First | 734,645 | $167,859,035 | 2.20% | |
| LLY |
ELI LILLY & Co
Healthcare
|
First | 146,473 | $157,411,618 | 2.07% | |
| ABT |
Abbott Laboratories
Healthcare
|
First | 1,214,297 | $152,139,270 | 2.00% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
First | 438,925 | $144,893,531 | 1.90% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
First | 3,773,564 | $144,187,880 | 1.89% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
First | 1,725,266 | $131,965,596 | 1.73% | |
| MCK |
Mckesson Corp
Healthcare
|
First | 154,593 | $126,811,091 | 1.66% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
First | 311,757 | $123,970,171 | 1.63% | |
| LGND |
Ligand Pharmaceuticals Inc
Healthcare
|
First | 644,093 | $121,778,663 | 1.60% | |
| PODD |
Insulet Corp
Healthcare
|
First | 420,832 | $119,617,287 | 1.57% | |
| AORT |
Artivion, Inc.
Healthcare
|
First | 2,613,471 | $119,200,412 | 1.56% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
First | 2,307,639 | $114,689,658 | 1.50% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
First | 496,837 | $105,945,521 | 1.39% | |
| TECH |
BIO-TECHNE Corp
Healthcare
|
First | 1,774,947 | $104,384,633 | 1.37% | |
| JNJ |
Johnson & Johnson
Healthcare
|
First | 502,785 | $104,051,355 | 1.37% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
First | 1,518,405 | $102,188,656 | 1.34% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
First | 832,241 | $101,242,117 | 1.33% | |
| MMSI |
Merit Medical Systems Inc
Healthcare
|
First | 1,146,304 | $101,035,234 | 1.33% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
First | 447,848 | $100,949,416 | 1.32% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
First | 1,831,505 | $98,791,378 | 1.30% | |
| CI |
Cigna Group
Healthcare
|
First | 356,490 | $98,116,742 | 1.29% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
First | 1,109,207 | $94,559,896 | 1.24% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
First | 1,177,990 | $93,485,285 | 1.23% | |
| PBH |
Prestige Consumer Healthcare Inc.
Healthcare
|
First | 1,421,966 | $87,721,082 | 1.15% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
First | 178,365 | $80,863,556 | 1.06% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
First | 2,038,703 | $80,651,090 | 1.06% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
First | 672,958 | $75,983,687 | 1.00% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
First | 5,069,590 | $72,190,961 | 0.95% | |
| ZTS |
Zoetis Inc.
Healthcare
|
First | 549,302 | $69,113,177 | 0.91% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
First | 864,892 | $68,421,606 | 0.90% | |
| ALGN |
Align Technology Inc
Healthcare
|
First | 423,382 | $66,111,099 | 0.87% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
First | 939,997 | $62,556,800 | 0.82% | |
| HQY |
Healthequity, Inc.
Healthcare
|
First | 634,175 | $58,096,771 | 0.76% | |
| PFE |
Pfizer Inc
Healthcare
|
First | 2,324,745 | $57,886,150 | 0.76% | |
| OMCL |
Omnicell, Inc.
Healthcare
|
First | 1,261,371 | $57,140,106 | 0.75% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
First | 9,328,744 | $54,386,577 | 0.71% | |
| ICLR |
Icon PLC
Healthcare
|
First | 270,059 | $49,210,150 | 0.65% | |
| BSX |
Boston Scientific Corp
Healthcare
|
First | 505,287 | $48,179,115 | 0.63% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
First | 584,686 | $47,874,089 | 0.63% | |
| NEO |
Neogenomics Inc
Healthcare
|
First | 3,939,140 | $46,324,286 | 0.61% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
First | 1,701,409 | $46,312,352 | 0.61% |